Portfolio
MDXHealth (MDXH.BR)
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer and for personalized treatment decisions. The company is committed to providing treating physicians with novel, accurate, and informative diagnostic tools.
OncoMethylome was founded in 2003, is headquartered in Belgium, and has offices and laboratories in Belgium, in the Netherlands, and in Durham, NC, USA.
OncoMethylome is now MDXHealth.
| Industry : | Diagnostic |
| Location : | Liège, Belgique |
| Funds : | La Banque Postale Innovation 1 |
| Contact: | Thomas Balland |